Publications by authors named "Eric Santoni-Rugiu"

Claim this Profile
T
Targeting uPARAP with an antibody-drug conjugate exhibits efficacy against mesothelioma and synergizes with cisplatin.
Pınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang, Kirstine Sandal Nørregaard, Henrik Gårdsvoll, Eric Santoni-Rugiu

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in diagnosis and management of pleural mesothelioma: the Danish clinical guidelines.
Vasiliki Panou, Jens Benn Sørensen, Jesper Ravn, Eric Santoni-Rugiu

Eur Clin Respir J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors.
Kristian Egebjerg, Iben Spanggaard, Lise Barlebo Ahlborn, Kristoffer Staal Rohrberg, Laurine Harsloef, Eric Santoni-Rugiu

BMC Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The recycling collagen receptor uPARAP is a unique mediator of stromal drug delivery to carcinoma cells.
Kirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen, Michaela Hansen Blomquist, Pınar Çakılkaya, Eric Santoni-Rugiu

Mol Cancer Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?
Edyta Maria Urbanska, Jens Benn Sørensen, Eric Santoni-Rugiu

J Thorac Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced -Rearranged NSCLC.
Edyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund, Linea Cecilie Melchior, Jens Benn Sørensen, Eric Santoni-Rugiu

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of or non-small cell lung cancer to crizotinib therapy.
Hui Jie, Hongjin Lai, Zihuai Wang, Min Yi, Yi Liu, Eric Santoni-Rugiu

Transl Lung Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alectinib impressively enters the adjuvant setting for early-stage -rearranged non-small cell lung cancer and outperforms chemotherapy-let's define who benefits the most.
Eric Santoni-Rugiu, Jens Benn Sørensen, Edyta Maria Urbanska

Transl Lung Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, characteristics, and comorbidities of a complete unselected Danish cohort of patients with thymic epithelial tumors.
Tine Østergaard, Caroline V A Bjerke, Eric Santoni-Rugiu, Thomas H L Jensen, Katharina A Perell

Acta Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Befotertinib in first-line treatment for Chinese non-small cell lung cancer patients harboring common EGFR-mutations reveals similar efficacy to other third-generation EGFR-TKIs but somewhat different safety profile.
Jens Benn Sørensen, Eric Santoni-Rugiu, Edyta Maria Urbanska

Chin Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma.
Luisa Bisceglia, Federica Morani, Lara Guerrieri, Eric Santoni-Rugiu, Pınar Çakılkaya

Cancer Gene Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK-tyrosine kinase inhibitor intrinsic resistance due to -amplification in metastatic -rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report.
Edyta M Urbanska, Morten Grauslund, Siv M S Berger, Junia C Costa, Peter R Koffeldt, Eric Santoni-Rugiu

Transl Lung Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To progress or not to progress: new insights into the evolution of pleuropulmonary blastomas come from studying lung cysts in adolescents and adults with -related tumour predisposition.
Eric Santoni-Rugiu

Thorax· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding One Treatment for All Advanced EGFR-positive NSCLC-An Infinite Task.
Edyta Maria Urbanska, Jens Benn Sørensen, Eric Santoni-Rugiu

J Thorac Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis.
Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen, Eric Santoni-Rugiu

Lung Cancer Manag· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring rearrangement.
Wenbin Hu, Jiaming Zhao, Guoxia Wang, Qihao Wang, Mingming Deng, Eric Santoni-Rugiu

Transl Lung Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Katia Damsgaard Højsager, Hanne Kobberø, Eric Santoni-Rugiu, Lotte Holm Land, Jens Benn Sørensen

Ugeskr Laeger· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of + non-small cell lung cancer in Denmark.
Karin Holmskov Hansen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen, Eric Santoni-Rugiu

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, Ayelet Peres, Eric Santoni-Rugiu

Cell Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo Amplification in Patients with Metastatic -Mutated NSCLC.
Edyta M Urbanska, Morten Grauslund, Peter R Koffeldt, Sarah L B Truelsen, Johan O Löfgren, Eric Santoni-Rugiu

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.
Wojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, Yilin Li, Kari Lavikka, Eric Santoni-Rugiu

Dev Cell· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?
Edyta Maria Urbanska, Jens Benn Sørensen, Eric Santoni-Rugiu

J Thorac Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lost in digitization - A systematic review about the diagnostic test accuracy of digital pathology solutions.
Olsi Kusta, Charlotte Vestrup Rift, Torsten Risør, Eric Santoni-Rugiu, John Brandt Brodersen

J Pathol Inform· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic Fusion in -Mutated Non-Small-Cell Lung Cancer.
Edyta M Urbanska, Jens B Sørensen, Linea C Melchior, Junia C Costa, Eric Santoni-Rugiu

JCO Precis Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma.
Eric Santoni-Rugiu, Maya Jeje Schuang Lü, Jan Nyrop Jakobsen, Linea Cecilie Melchior, Jesper Ravn

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis